Predictmedix AI Inc C.PMED

Alternate Symbol(s): PMEDF

Predictmedix AI Inc. is a life sciences technology company. The Company, through its subsidiaries, focuses on artificial intelligence (AI) technologies which target two specific areas: workplace health and safety and healthcare. It has developed a technology for the identification and detection of infectious disease symptoms, including COVID-19, referred to as its infectious disease symptom screening solutions (IDSS) and marketed in North America under the name Safe Entry System. It is also developing AI-powered products that address detection of alcohol and/or cannabis impairment in individuals; mental illness screening, and remote patient monitoring and treatment plans, referred to as the Mobile Wellbeing product. It is adding additional modules to this Mobile Wellbeing platform that enable us to use a patient’s history and real-time medical data, such as blood pressure, and to provide patients and their medical professionals with treatment plans for chronic disease management.

CSE:PMED - Post by User

Predictmedix AI Inc > PMED Partners With McGill Researchers for Clinical Research

<< Previous

Bullboard Posts

Next >>

Comment by badog222on Nov 16, 2020 10:32am

96 Views

Post# 31906177

RE:PMED Partners With McGill Researchers for Clinical Research

Come on....partnering with McGill researchers????

The object is to actually get contracts with sales/revenues. The more outfits you partner with the more contracts one would think. News headlines that don't indicate revenues are not impressive to investors.

All IMHO.

Badog

Predictmedix Inc. (CSE:PMED)(OTCQB:PMEDF) ("Predictmedix" or the "Company") is pleased to announce that the company is partnering with the research group led by Dr. Samira Rahimi for clinical research.

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec